Trupanion (TRUP) has drawn fresh attention after announcing two partnerships that target key friction points in pet care. These moves focus on insurance education, easier claims and closer ties with veterinarians and adopters.

Against this backdrop of new partnerships, Trupanion’s share price has climbed in recent months, with a 90 day share price return of 38.59% and a 30 day share price return of 14.61%, although the 1 year total shareholder return has declined 37.02%.

If this kind of momentum in pet care gets you thinking about other opportunities, it could be a useful moment to scan for 21 top founder-led companies

Trupanion now sits at the intersection of growing pet insurance awareness and a share price that has moved sharply in recent months. The real question is whether that business strength is already reflected in today’s valuation.

Most Popular Narrative: 17.9% Undervalued

Trupanion's most followed narrative suggests a fair value of $37.25 compared with the last close at $30.60. This frames the recent share price move against a higher long term valuation anchor.

The moderation in veterinary care inflation, with Trupanion's pricing now catching up and a value proposition restored to target, should lead to more modest premium increases, aiding retention and lowering churn, thereby increasing customer lifetime value and supporting both revenue and earnings stability.

If you are wondering how this narrative gets to that higher fair value, the core ingredients are sustained revenue growth, firmer margins and a richer future earnings multiple.

Result: Fair Value of $37.25 (UNDERVALUED)

However, Trupanion’s story could change quickly if subscriber growth stays muted and the other business segment slows further, which would put more pressure on pricing and margins.

Another View On Trupanion’s Valuation

The popular narrative around Trupanion points to a fair value of $37.25 that suggests the stock looks 17.9% undervalued. Yet on a simple earnings multiple, the picture changes. Trupanion currently trades on a P/E of 57.8x, which is far above several key reference points.

That 57.8x compares with a fair ratio of 16.4x, the US Insurance industry average of 11.5x and a peer average of 10.6x. This gap implies investors are already paying a steep premium for Trupanion’s earnings, which raises the question of how much further upside that valuation leaves if expectations slip.

Next Steps

With sentiment on Trupanion split between valuation concerns and optimism about future rewards, this is a good moment to move quickly and test the data yourself through the 2 key rewards.

Looking for more investment ideas beyond Trupanion?

Trupanion may already be on your radar, but you do not want to stop at a single stock when there are other compelling angles to consider.

• Expand your opportunity set by scanning 21 elite penny stocks with strong financials that pair smaller market caps with more established financial profiles.
• Zero in on potential value by reviewing the screener containing 19 high quality undiscovered gems that combine quality fundamentals with relatively low market attention.
• Prioritise resilience by checking the 80 resilient stocks with low risk scores that score well on financial strength and risk metrics.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.